159 related articles for article (PubMed ID: 12541094)
1. Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy.
Hara Y; Hamada M; Ohtsuka T; Ogimoto A; Saeki H; Matsunaka T; Suzuki J; Shigematsu Y
Heart Vessels; 2002 Dec; 17(2):53-6. PubMed ID: 12541094
[TBL] [Abstract][Full Text] [Related]
2. Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure.
Davis ME; Richards AM; Nicholls MG; Yandle TG; Frampton CM; Troughton RW
Circulation; 2006 Feb; 113(7):977-85. PubMed ID: 16476851
[TBL] [Abstract][Full Text] [Related]
3. An appropriate indication for the initiation of beta-blocker therapy in dilated cardiomyopathy.
Morooka T; Inoue T; Kotooka N; Fujimatsu D; Komatsu A; Uchida F; Yoshida K; Hashimoto S; Hikichi Y; Kato T; Node K
Cardiology; 2006; 105(1):61-6. PubMed ID: 16272814
[TBL] [Abstract][Full Text] [Related]
4. Changes in natriuretic peptides following passive containment surgery in heart failure patients with dilated cardiomyopathy.
Bredin F; Liska J; Franco-Cereceda A
Interact Cardiovasc Thorac Surg; 2009 Feb; 8(2):191-4. PubMed ID: 19008326
[TBL] [Abstract][Full Text] [Related]
5. Dilated cardiomyopathy with hypertension: prevalence and response to high-dose β1-adrenoceptor antagonist therapy.
Zheng X; Chen S; Wang J; Yang T; Chen Y
Clin Exp Pharmacol Physiol; 2009 Sep; 36(9):945-9. PubMed ID: 19473337
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effect of beta-adrenergic blockade on left ventricular function in haemodialysis patients.
Hara Y; Hamada M; Shigematsu Y; Murakami B; Hiwada K
Clin Sci (Lond); 2001 Sep; 101(3):219-25. PubMed ID: 11524038
[TBL] [Abstract][Full Text] [Related]
7. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
[TBL] [Abstract][Full Text] [Related]
8. Comparative left ventricular functional and neurohumoral effects of chronic treatment with carvedilol versus metoprolol in patients with dilated cardiomyopathy.
Hirooka K; Yasumura Y; Ishida Y; Hanatani A; Nakatani S; Komamura K; Hori M; Yamagishi M; Miyatake K
Jpn Circ J; 2001 Nov; 65(11):931-6. PubMed ID: 11716241
[TBL] [Abstract][Full Text] [Related]
9. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels.
Nakajima K; Onishi K; Dohi K; Tanabe M; Kurita T; Yamanaka T; Ito M; Isaka N; Nobori T; Nakano T
Int J Cardiol; 2005 Oct; 104(3):332-7. PubMed ID: 16186065
[TBL] [Abstract][Full Text] [Related]
10. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
[TBL] [Abstract][Full Text] [Related]
11. Baseline and serial neurohormones in patients with congestive heart failure treated with and without bucindolol: results of the neurohumoral substudy of the Beta-Blocker Evaluation of Survival Study (BEST).
Frantz RP; Lowes BD; Grayburn PA; White M; Krause-Steinrauf H; Krishnan V; Uyeda L; Burnett JC;
J Card Fail; 2007 Aug; 13(6):437-44. PubMed ID: 17675057
[TBL] [Abstract][Full Text] [Related]
12. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of natriuretic peptides in Chagas' disease: a 3-year follow-up investigation.
Moreira Mda C; Heringer-Walther S; Wessel N; Moreira Ventura T; Wang Y; Schultheiss HP; Walther T
Cardiology; 2008; 110(4):217-25. PubMed ID: 18073475
[TBL] [Abstract][Full Text] [Related]
14. Myocardial gene expression in dilated cardiomyopathy treated with beta-blocking agents.
Lowes BD; Gilbert EM; Abraham WT; Minobe WA; Larrabee P; Ferguson D; Wolfel EE; Lindenfeld J; Tsvetkova T; Robertson AD; Quaife RA; Bristow MR
N Engl J Med; 2002 May; 346(18):1357-65. PubMed ID: 11986409
[TBL] [Abstract][Full Text] [Related]
15. Effects of immunoadsorption on the nt-BNP and nt-ANP plasma levels of patients suffering from dilated cardiomyopathy.
Staudt A; Staudt Y; Hummel A; Empen K; Dörr M; Trimpert C; Birkenmeier K; Kühl U; Noutsias M; Russ D; Felix SB
Ther Apher Dial; 2006 Feb; 10(1):42-8. PubMed ID: 16556135
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of heart rate in dilated cardiomyopathy treated with metoprolol.
Perkan A; Di Lenarda A; Sinagra G; Gregori D; Cherubini A; Zecchin M; Gortan R; Klugmann S; Camerini F
G Ital Cardiol; 1997 Nov; 27(11):1106-12. PubMed ID: 9419820
[TBL] [Abstract][Full Text] [Related]
17. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
[TBL] [Abstract][Full Text] [Related]
18. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
[TBL] [Abstract][Full Text] [Related]
19. Effect of left ventricular reverse remodeling on long-term prognosis after therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers and β blockers in patients with idiopathic dilated cardiomyopathy.
Hoshikawa E; Matsumura Y; Kubo T; Okawa M; Yamasaki N; Kitaoka H; Furuno T; Takata J; Doi YL
Am J Cardiol; 2011 Apr; 107(7):1065-70. PubMed ID: 21296328
[TBL] [Abstract][Full Text] [Related]
20. Metoprolol-induced functional benefit in dilated cardiomyopathy is sustained over four years and favorably influences outcome.
De Maria R; Di Lenarda A; Gavazzi A; Porcu M; Sinagra G; Parolini M;
Ital Heart J; 2001 Feb; 2(2):130-8. PubMed ID: 11256541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
